Individuals with ARTHS present with developmental delay, cognitive impairment (100% penetrance), delay or absence of speech (100%), facial dysmorphism (85%), feeding difficulties (78%), and neonatal hypotonia (76%) in a study of 76 individuals with KAT6A mutations (Kennedy et al, 2019)
Contact your provider if you experience bloody stools, signs of dehydration (extreme thirst, dark urine, dizziness), severe abdominal pain, or diarrhea accompanied by fever
Interest in the relationship between GLP-1 medications and eye health increased after researchers published a study in JAMA Ophthalmology that found a possible association between semaglutide use and NAION
(Or, even tougher, if your clinician appears squeamish or unwilling to discuss it.) Start by finding a trusted, menopause-informed provider who doesnt shy away from any topic, like a Midi clinician
Patented formulas
Semaglutide functions as a GLP-1 receptor agonist, which means it mimics the action of the glucagon-like peptide-1 hormone in the body